Grantable
Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing: Option B Grant · GATES FOUNDATION
Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing: Option B Grant Status: ACTIVE Funder: Gates Foundation Last Updated: February 19, 2025 Summary The Bill & Melinda Gates Foundation invites innovative proposals to develop low-cost …
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.